Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Story time
View:
Post by fossi_2002 on Sep 27, 2023 11:21am

Story time

Every day here we listen to the fairy tale lesson of Proph... .
Proph... compares Ceapro with other biotech stocks. But we are miles away from a biotech share and are only the manufacturer of basic products that are used in the cosmetics industry.
Proph... we would like to listen to your stories, but we are obviously too old to believe your and Gilles' fairy tales.
Do you actually listen to what the stock market is saying, these are not fairy tales, this is reality.



Comment by prophetoffactz on Sep 27, 2023 11:37am
I know you like to sit back, contribute nothing, and take pot shots from the bleechers at those trying to advance the case. Why don't you outline the case of the pipeline, fossi. A Phase I/IIa clinical trial has been approved and it expected to commence recruiting in 1 1/2 months. Clinical trials are what biotech and biopharma companies run. The fibrosis clinical trial is undergoing a ...more  
Comment by fossi_2002 on Sep 27, 2023 11:55am
Proph... I hear your call - but I lack faith. And believe me - all of us here wish that your predictions would come true. But the past has taught us: Gilles' forecasts are not to be trusted - and unfortunately you are nothing else than his secret press spokesman.
Comment by prophetoffactz on Sep 27, 2023 12:32pm
You have never advanced a rational case for a single pipeline asset and consistent with that you talk about faith, fossi. You are an emotional, faith based investor and not a rational investor in the business. You say Gilles forecasts are not to be trusted when he delivered a decade of double diget growth for the base business. Symrise has complemented and expanded the relationship. The company ...more  
Comment by Hopeforthebest on Sep 27, 2023 12:06pm
You know Fossi, it appears that the investment community agrees with what you have said. As I have said previously said, once Q3 results are tabled this stock will fall in the $0.20. No news by management at this time to stem the drop is an indication that Q3 results will be poor as they already know what the numbers are and if the do not they are even worst than we think. I also took the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse